Brighten Optix Corporation (TPEX:6747)
Taiwan · Delayed Price · Currency is TWD 195.00
-0.50 (-0.26%)
Sep 19, 2025, 9:51 AM CST
Brighten Optix Market Cap
Brighten Optix has a market cap or net worth of 5.32 billion as of September 18, 2025. Its market cap has increased by 30.33% in one year.
Market Cap
5.32B
Enterprise Value
4.92B
Revenue
778.00M
Ranking
n/a
PE Ratio
87.08
Stock Price
195.00
Market Cap Chart
Since October 7, 2019, Brighten Optix's market cap has increased from 2.82B to 5.32B, an increase of 88.85%. That is a compound annual growth rate of 11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 5.32B | 46.99% |
| Dec 31, 2024 | 3.62B | -21.08% |
| Dec 29, 2023 | 4.58B | 1.61% |
| Dec 30, 2022 | 4.51B | -37.73% |
| Dec 30, 2021 | 7.24B | 133.55% |
| Dec 31, 2020 | 3.10B | 6.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 307.10B |
| PharmaEssentia | 181.77B |
| Bora Pharmaceuticals Co., LTD. | 88.24B |
| Lumosa Therapeutics | 53.74B |
| Lotus Pharmaceutical | 48.91B |
| Oneness Biotech | 33.67B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.25B |